CME.NASDAQCme Group INC

Form 4: CME Group Director Charles P. Carey Sells 3,000 Shares of Class A Common Stock

Sentiment:

SEC Form 4 Filing


Charles P. Carey, a director of CME Group Inc., sold 3,000 shares of Class A common stock on May 15, 2025, at a weighted average price of $272.56.

Summary

  • On May 15, 2025, Charles P. Carey, a director of CME Group Inc., sold 3,000 shares of Class A common stock.
  • The sale was executed at a weighted average price of $272.56 per share.
  • The price range for the sale was between $272.21 and $272.90.
  • Following the transaction, Mr. Carey directly owns 5,400 shares and indirectly owns 185 shares by Firm and 0.375 shares by Partnership.
  • The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of a stock sale by a company director. The sale itself doesn't necessarily indicate a positive or negative outlook.

Industry Context

This is a routine disclosure of a transaction by a company insider. It's common for directors and officers to buy and sell shares of their company's stock, and these transactions are closely monitored by regulators and investors.

Stakeholder Impact

  • The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the director's reasons for selling.

Key Dates

DateDescription
05/15/2025Date of the transaction: Charles P. Carey sold 3,000 shares of CME Group Class A common stock.
05/19/2025Date of the Form 4 filing.

Keywords

CME Group, Charles P. Carey, Form 4, Stock Sale, Director, Class A Common Stock, Beneficial Ownership, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.